RxDoctor Payments Data

Bennett Hogan, MD

Family Medicine · Valdosta, GANPI 1205891397

Payments from drug & device makers

$2,162in general payments, 2019–2025

Across 120 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$335
  • AstraZeneca$171
  • Johnson & Johnson$159
  • AbbVie$136
  • Idorsia Pharmaceuticals US Inc$126
  • Abbott$118
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,162 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$206,151
Medicare patients
1,131
Services billed
5,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban193$149,876
JardianceEmpagliflozin70$74,079
JanuviaSitagliptin Phosphate89$72,972
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$41,344
MyrbetriqMirabegron50$37,674
OzempicSemaglutide41$37,283
MounjaroTirzepatide32$35,364
TrulicityDulaglutide18$21,879
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog47$21,435
FarxigaDapagliflozin Propanediol14$21,368
EntrestoSacubitril/Valsartan21$20,405
LinzessLinaclotide21$18,003
GlyxambiEmpagliflozin/Linagliptin13$16,770
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$16,197
ShingrixVaricella-Zoster Ge/As01b/Pf68$14,634

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$335$163,797238 claims
Lilly USA, LLCMounjaro, Trulicity$111$57,24250 claims
GSKTrelegy Ellipta, Shingrix, Anoro Ellipta$117$40,00499 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$171$39,38663 claims
Novo NordiskOzempic$56$37,28341 claims
AbbVieLinzess$136$18,00321 claims
Johnson & JohnsonXarelto$159$13,45923 claims
Sanofi-aventis U.S. LLCLantus$40$3,83522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →